Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00205179
Status:
COMPLETED
Last Update Posted:
2020-01-22
First Post:
2005-09-13
Brief Title:
Alzheimers Disease Potential Benefit of Isoflavones
Sponsor:
University of Wisconsin Madison
Organization:
University of Wisconsin Madison
Study Overview
Official Title:
Alzheimers Disease Potential Benefit of Isoflavones
Status:
COMPLETED
Status Verified Date:
2020-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this pilot study is to evaluate the potential effects of soy isoflavone supplements on cognitive function for men and women with Alzheimers Disease AD Preliminary studies evaluating the effects of soy supplements on memory in cognitively healthy older adults have yielded promising results that are now being evaluated in patients with AD It is hypothesized that isoflavone supplements will ameliorate cognitive declines for older adults diagnosed with Alzheimers disease when compared to subjects on placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| SMPHMEDICINEMEDICINEG | OTHER | University of Wisconsin Madison | httpsreporternihgovquickSearch5K23AG024302-03 |
| 5K23AG024302-03 | NIH | None | None |
| A534255 | OTHER | None | None |